Production of
iPS cells in the laboratory is becoming more widespread.
Not exact matches
In close collaboration with Dr. Yamanaka Dr. Conklin's
laboratory was able to establish new
iPS cell disease models, gain new insights into
iPS cell biology, and develop new tissue engineering methods.
Dr. Conklin's
laboratory has developed new method genome engineering
in human
iPS cells using the TALENs and CRISPR system.
This effort extended
in collaborations with
laboratories focusing on correcting mutations
in patient - specific
iPS cells.
Embryonic stem
cells and
iPS cells can be grown
in large number
in the
laboratory and have the potential to be coaxed into becoming any
cell type
in the body, including glucose sensing, insulin - producing beta
cells.